|
I, the undersigned official veterinarian, hereby certify that:
|
II.1.
|
The bovine animals (1) of the consignment described in Part I meet the following requirements:
|
II.1.1.
|
They are identified as provided for in Article 38 of Commission Delegated Regulation (EU) 2019/2035.
|
|
II.1.2.
|
They, for at least 30 days prior to the date of departure of the consignment, or since birth, if they are younger than 30 days of age:
|
II.1.2.1.
|
have been continuously resident in the establishment of origin;
|
|
II.1.2.2.
|
have not been in contact with kept bovine animals of a lower health status or subject to movement restrictions for animal health reasons;
|
|
II.1.2.3.
|
have not been in direct or indirect contact with kept animals that have entered the Union from a third country or territory during the last 30 days prior to the date of departure of the animals.
|
|
|
II.1.3.
|
They have not shown clinical signs or symptoms of diseases listed for bovine animals during the clinical examination which was carried out, within the last 24 hours prior to the time of departure of the consignment, on … (insert date dd/mm/yyyy).
|
|
|
II.2.
|
According to official information, the animals described in Part I meet the following health requirements:
|
II.2.1.
|
|
(2)
either
|
[They come from establishments or zones not subject to movement restrictions affecting bovine animals and established for reasons of diseases listed for those species or diseases subject to emergency measures relevant for those species, and they have not been in contact with kept animals of a listed species of a lower health status for an adequate period.]
|
|
(2)
or
|
[They come from establishments or zones subject to movement restrictions affecting bovine animals and established for … (3), but derogations from movement restrictions have been granted, and:
|
|
(2)
|
[they comply with the requirements set out in …(4);]]
|
|
(2)
|
[and in particular, they are … (5).]]
|
|
|
II.2.2.
|
They come from establishments free from infection with Brucella abortus, B. melitensis and B. suis without vaccination regarding bovine animals, and:
|
|
(2)
either
|
[the establishments of origin are situated in a Member State or zone thereof with the status free from infection with Brucella abortus, B. melitensis and B. suis regarding the bovine population;]
|
|
(2)
and/or
|
[they have been subjected to a test for infection with Brucella abortus, B. melitensis and B. suis with one of the diagnostic methods provided for in Part 1 of Annex I to Commission Delegated Regulation (EU) 2020/688, carried out, with negative results, on a sample taken during the last 30 days prior to the date of departure, and in the case of post-parturient females taken at least 30 days after parturition;]
|
|
(2)
and/or
|
[they are less than 12 months old;]
|
|
(2)
and/or
|
[they are castrated.]
|
|
II.2.3.
|
They come from establishments free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), and:
|
|
(2)
either
|
[the establishments of origin are situated in a Member State or zone thereof with the status free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis);]
|
|
(2)
and/or
|
[they have been subjected to a test for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) with one of the diagnostic methods provided for in Part 2 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, during the last 30 days prior to the date of departure of the consignment;]
|
|
(2)
and/or
|
[they are less than 6 weeks old.]
|
|
II.2.4.
|
They come from establishments in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to the date of departure of the consignment.
|
|
II.2.5.
|
They come from establishments situated in an area of at least 150 km radius around those establishments in which infection with epizootic haemorrhagic disease virus:
|
|
(2)
either
|
[has not been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment;]
|
|
(2)
and/or
|
[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been kept in a zone seasonally free from epizootic haemorrhagic disease in accordance with Parts 1 and 2 of Annex IX to Delegated Regulation (EU) 2020/688:
|
(2)
either
|
[for at least 60 days prior to the date of departure of the consignment;]]
|
|
(2)
and/or
|
[for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the seasonally disease-free area;]]
|
|
(2)
and/or
|
[for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals into the seasonally disease-free area;]]
|
|
|
(2)
and/or
|
[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been protected against attacks by vectors during transportation to the place of destination and they have been kept protected against attacks by vectors in a vector protected establishment fulfilling the requirements provided for in Part 3 of Annex IX to Delegated Regulation (EU) 2020/688:
|
(2)
either
|
[for at least 60 days prior to the date of departure of the consignment;]]
|
|
(2)
and/or
|
[for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]
|
|
(2)
and/or
|
[for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of commencement of the period of protection against attacks by vectors;]]
|
|
|
(2)
and/or
|
[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been vaccinated against infection with epizootic haemorrhagic disease virus and the animals are within the immunity period guaranteed in the specifications of the vaccine and:
|
(2)
either
|
[they have been vaccinated at least 60 days prior to the date of departure of the consignment;]]
|
|
(2)
and/or
|
[they have been vaccinated with an inactivated vaccine and have been subject to a PCR test, with negative results on samples collected at least 14 days after the onset of the immunity set in the specifications of the vaccine;]]
|
|
|
(2)
and/or
|
[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the Member State of destination has informed the Commission and the other Member States that such movement is authorised;]
|
|
(2)
and/or
|
[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals comply with specific risk-mitigating measures defined by the competent authority of the Member State of destination and the Member State of destination has informed the Commission and the other Member States that such movement is authorised;]
|
|
(2)
and
|
[the requirements laid down in Article 10(1), third subparagraph, of Delegated Regulation (EU) 2020/688 are fulfilled.]
|
|
II.2.6.
|
They come from establishments in which anthrax in ungulates has not been reported during the last 15 days prior to the date of departure of the consignment.
|
|
II.2.7.
|
They come from establishments in which surra (Trypanosoma evansi) has not been reported during the last 30 days prior to the date of departure of the consignment, and
|
|
(2)
either
|
[surra has not been reported in the establishments during the last 2 years prior to the date of their departure.]
|
|
(2)
or
|
[surra has been reported during the last 2 years prior to the date of departure of the consignment, and following the date of the last outbreak, the affected establishments have remained under movement restrictions until the date on which the infected animals have been removed from the establishments, and the remaining animals in the establishments have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months following the date on which the infected animals have been removed from the establishments.]
|
|
|
(2)
either
|
|
[II.2.8.
|
They originate from a Member State or a zone thereof free from infection with bluetongue virus (serotypes 1-24), where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed in the targeted animal population during the last 24 months prior to the date of departure of the consignment, and have not been vaccinated with a live vaccine against infection with bluetongue virus (serotypes 1-24) in the last 60 days prior to the date of departure of the consignment and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled.]
|
|
|
(2)
and/or
|
|
[II.2.8.
|
They originate from a Member State or a zone thereof covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and they:
|
|
(2)
either
|
|
[II.2.8.1.
|
have been kept in a Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24) in accordance with Article 40(3) of Commission Delegated Regulation (EU) 2020/689:
|
|
(2)
either
|
|
[II.2.8.1.1.
|
for at least 60 days prior to the date of departure of the consignment;]]
|
|
|
(2)
and/or
|
|
[II.2.8.1.2.
|
for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24);]]
|
|
|
(2)
and/or
|
|
[II.2.8.1.3.
|
for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals into the Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24);]]]
|
|
|
|
(2)
and/or
|
|
[II.2.8.2.
|
have been protected against attacks by vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector protected establishment:
|
|
(2)
either
|
|
[II.2.8.2.1.
|
for at least 60 days prior to the date of departure of the consignment;]]
|
|
|
(2)
and/or
|
|
[II.2.8.2.2.
|
for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]
|
|
|
(2)
and/or
|
|
[II.2.8.2.3.
|
for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of the commencement of the period of protection against attacks by vectors;]]]
|
|
|
|
(2)
and/or
|
|
[II.2.8.3.
|
have been vaccinated against all serotypes 1-24 of infection with bluetongue virus which were reported in that Member State or zone thereof during the last 2 years prior to the date of departure of the consignment and are within the immunity period guaranteed in the specifications of the vaccine and:
|
|
(2)
either
|
|
[II.2.8.3.1.
|
have been vaccinated more than 60 days prior to the date of departure of the consignment;]]
|
|
|
(2)
and/or
|
|
[II.2.8.3.2.
|
have been vaccinated with an inactivated vaccine and subjected to a PCR test, with negative results, carried out on samples collected at least 14 days after the date of the onset of the immunity set in the specifications of the vaccine;]]]
|
|
|
|
(2)
and/or
|
|
[II.2.8.4.
|
have been subjected with positive results to a serological test able to detect specific antibodies against all serotypes 1-24 of infection with bluetongue virus reported in that Member State or zone thereof during the last 2 years prior to the date of departure of the consignment, and:
|
|
(2)
either
|
|
[II.2.8.4.1.
|
the serological test has been carried out on samples collected at least 60 days prior to the date of departure of the consignment.]]]
|
|
|
(2)
and/or
|
|
[II.2.8.4.2.
|
the serological test has been carried out on samples collected at least 30 days prior to the date of departure of the consignment and the animals have been subjected to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of departure of the consignment.]]]
|
|
|
|
|
(2)
and/or
|
|
[II.2.8.
|
They originate from a Member State or a zone thereof neither free from infection with bluetongue virus (serotypes 1-24) nor covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and they:
|
|
(2)
either
|
|
[II.2.8.1.
|
have been protected against attacks by vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector protected establishment:
|
|
(2)
either
|
|
[II.2.8.1.1.
|
for at least 60 days prior to the date of departure of the consignment;]]
|
|
|
(2)
and/or
|
|
[II.2.8.1.2.
|
for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]
|
|
|
(2)
and/or
|
|
[II.2.8.1.3.
|
for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of the commencement of the period of protection against attacks by vectors;]]]
|
|
|
|
(2)
and/or
|
|
[II.2.8.2.
|
have been kept for the last 60 days prior to the date of departure of the consignment in an establishment situated in a Member State or within an area of at least 150 km radius centred on the establishment, where surveillance in compliance with the requirements set out in Part II, Chapter 1, Sections 1 and 2, of Annex V to Delegated Regulation (EU) 2020/689 has been carried out during that period, and:
|
|
(2)
either
|
|
[II.2.8.2.1.
|
the animals have been vaccinated against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the date of departure of the consignment within an area of at least 150 km radius centred on the place where the animals were kept and are within the immunity period guaranteed in the specifications of the vaccine, and:
|
|
(2)
either
|
|
[II.2.8.2.1.1.
|
have been vaccinated more than 60 days prior to the date of departure of the consignment;]]]
|
|
|
(2)
and/or
|
|
[II.2.8.2.1.2.
|
have been vaccinated with an inactivated vaccine and subjected to a PCR test, with negative results on samples collected at least 14 days after the date of onset of the immunity set in the specifications of the vaccine;]]]]
|
|
|
|
(2)
and/or
|
|
[II.2.8.2.2.
|
the animals have been immunised against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the date of departure of the consignment in an area of at least 150 km radius centred on the place where the animals were kept, and:
|
|
(2)
either
|
|
[II.2.8.2.2.1.
|
the animals have been subjected with positive results to a serological test carried out on samples collected at least 60 days prior to the date of departure of the consignment;]]]
|
|
|
(2)
and/or
|
|
[II.2.8.2.2.2.
|
the animals have been subjected with positive results to a serological test carried out on samples collected at least 30 days prior to the date of the departure of the consignment and to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of departure of the consignment.]]]]
|
|
|
|
|
|
(2)
and/or
|
|
[II.2.8.
|
They do not fulfil the requirements laid down in Part II, Chapter 2, Section 1, points 1 to 3, of Annex V to Delegated Regulation (EU) 2020/689 and the competent authority of the Member State of origin authorised movement of those animals to another Member State or zone thereof:
|
|
(2)
either
|
|
[II.2.8.1.
|
with the status free from infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised subject to the conditions referred to in Article 43(2), points (a), (b) and (c), of Delegated Regulation (EU) 2020/689, and:
|
|
(2)
either
|
|
[II.2.8.1.1.
|
Part II, Chapter 2, Section 1, point 5, of Annex V to that Delegated Regulation, and
|
|
|
(2)
and/or
|
|
[II.2.8.1.2.
|
Part II, Chapter 2, Section 1, point 6, of Annex V to that Delegated Regulation, and
|
|
|
(2)
and/or
|
|
[II.2.8.1.3.
|
Part II, Chapter 2, Section 1, point 7, of Annex V to that Delegated Regulation, and
|
|
|
(2)
and/or
|
|
[II.2.8.1.4.
|
Part II, Chapter 2, Section 1, point 8, of Annex V to that Delegated Regulation, and
|
the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled;]]
|
|
|
(2)
and/or
|
|
[II.2.8.2.
|
with an approved eradication programme for infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised subject to the conditions referred to in Article 43(2), points (a), (b) and (c), of Delegated Regulation (EU) 2020/689, and:
|
|
(2)
either
|
|
[II.2.8.2.1.
|
Part II, Chapter 2, Section 1, point 5, of Annex V to that Delegated Regulation, and
|
|
|
(2)
and/or
|
|
[II.2.8.2.2.
|
Part II, Chapter 2, Section 1, point 6, of Annex V to that Delegated Regulation, and
|
|
|
(2)
and/or
|
|
[II.2.8.2.3.
|
Part II, Chapter 2, Section 1, point 7, of Annex V to that Delegated Regulation, and
|
|
|
(2)
and/or
|
|
[II.2.8.2.4.
|
Part II, Chapter 2, Section 1, point 8, of Annex V to that Delegated Regulation, and
|
the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled;]]]
|
|
|
(2)
and/or
|
|
[II.2.8.3.
|
neither free from infection with bluetongue virus (serotypes 1-24) nor covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised:
|
|
(2)
either
|
|
[II.2.8.3.1.
|
without any conditions, and
|
|
|
(2)
and/or
|
|
[II.2.8.3.2.
|
subject to the conditions referred to in Part II, Chapter 2, Section 1, point 5, of Annex V to Delegated Regulation (EU) 2020/689, and
|
|
|
(2)
and/or
|
|
[II.2.8.3.3.
|
subject to the conditions referred to in Part II, Chapter 2, Section 1, point 6, of Annex V to Delegated Regulation (EU) 2020/689, and
|
|
|
(2)
and/or
|
|
[II.2.8.3.4.
|
subject to the conditions referred to in Part II, Chapter 2, Section 1, point 7, of Annex V to Delegated Regulation (EU) 2020/689, and
|
|
|
(2)
and/or
|
|
[II.2.8.3.5.
|
subject to the conditions referred to in Part II, Chapter 2, Section 1, point 8, of Annex V to Delegated Regulation (EU) 2020/689, and
|
the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled.]]]
|
|
|
|
(2) [(2)
either
|
|
[II.2.9.
|
They are moved to a Member State or zone thereof with the status free from enzootic bovine leukosis, and
|
|
(2)
either
|
|
[II.2.9.1.
|
they come from establishments free from enzootic bovine leukosis.]]]
|
|
|
(2)
or
|
|
[II.2.9.1.
|
they come from establishments not free from enzootic bovine leukosis, and enzootic bovine leukosis has not been reported in those establishments during the last 24 months prior to the date of departure of the consignment, and:
|
|
(2)
either
|
|
[II.2.9.1.1.
|
they are over 24 months of age and they have been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I to Delegated Regulation (EU) 2020/688, carried out with negative results:
|
|
(2)
either
|
|
[II.2.9.1.1.1.
|
on samples taken on two occasions at an interval of at least 4 months while kept in isolation from the other bovine animals of the establishment;]]]]
|
|
|
(2)
and/or
|
|
[II.2.9.1.1.2.
|
on a sample taken during the last 30 days prior to the date of departure of the consignment, and all bovine animals over 24 months of age kept in the establishment have been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken on two occasions at an interval of not less than 4 months during the last 12 months prior to the date of departure of the consignment;]]]]
|
|
|
|
(2)
and/or
|
|
[II.2.9.1.2.
|
they are less than 24 months of age and they were born to dams subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken on two occasions at an interval of not less than 4 months during the last 12 months prior to the date of departure of the consignment.]]]
|
|
|
|
|
(2)
or
|
|
[II.2.9.
|
They are moved to a Member State or zone thereof with an approved eradication programme for enzootic bovine leukosis, and
|
|
(2)
either
|
|
[II.2.9.1.
|
they come from establishments free from enzootic bovine leukosis.]]
|
|
|
(2)
or
|
|
[II.2.9.1.
|
they come from establishments not free from enzootic bovine leukosis, and enzootic bovine leukosis has not been reported in those establishments during the last 24 months prior to the date of departure of the consignment, and:
|
|
(2)
either
|
|
[II.2.9.1.1.
|
they are over 24 months of age and they have been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I to Delegated Regulation (EU) 2020/688, carried out with negative results:
|
|
(2)
either
|
|
[II.2.9.1.1.1.
|
on samples taken on two occasions at an interval of at least 4 months while kept in isolation from the other bovine animals of the establishment;]]]]
|
|
|
(2)
and/or
|
|
[II.2.9.1.1.2.
|
on a sample taken during the last 30 days prior to the date of departure of the consignment, and all bovine animals over 24 months of age kept in the establishment have been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken on two occasions at an interval of not less than 4 months during the last 12 months prior to the date of departure of the consignment;]]]]
|
|
|
|
(2)
and/or
|
|
[II.2.9.1.2.
|
they are less than 24 months of age and they were born to dams, subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken on two occasions at an interval of not less than 4 months during the last 12 months prior to the date of departure of the consignment.]]]]
|
|
|
|
|
(2) [(2)
either
|
|
[II.2.10.
|
They are moved to a Member State or zone thereof with the status free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and they have not been vaccinated against infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, and
|
|
(2)
either
|
|
[II.2.10.1.
|
they come from establishments free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, and:
|
|
(2)
either
|
|
[II.2.10.1.1.
|
the establishments of origin are situated in a Member State or zone thereof with the status free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis;]]]]
|
|
|
(2)
and/or
|
|
[II.2.10.1.2
|
the animals have been subjected to quarantine for at least 30 days prior to the date of departure of the consignment and have been subjected to a serological test for the detection of antibodies against whole bovine herpes virus-1 (BoHV-1) with one of the diagnostic methods provided for in Part 5 of Annex I to Delegated Regulation (EU) 2020/688, with a negative result, carried out on a sample taken during the last 15 days prior to the date of departure of the consignment.]]]]
|
|
|
|
(2)
or
|
|
[II.2.10.1.
|
they come from establishments not free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and they have been kept in an approved quarantine establishment for at least 30 days prior to the date of departure of the consignment and have been subjected to a serological test for the detection of antibodies against whole BoHV-1, with one of the diagnostic methods provided for in Part 5 of Annex I to Delegated Regulation (EU) 2020/688, with a negative result, carried out on a sample taken not less than 21 days after the date of commencement of the quarantine.]]]
|
|
|
|
(2)
or
|
|
[II.2.10.
|
They are moved to a Member State or zone thereof with an approved eradication programme for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, and
|
|
(2)
either
|
|
[II.2.10.1.
|
they come from establishments free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, and:
|
|
(2)
either
|
|
[II.2.10.1.1.
|
the establishments of origin are situated in a Member State or zone thereof with the status free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis;]]]]
|
|
|
(2)
and/or
|
|
[II.2.10.1.2.
|
the establishments of origin are situated in a Member State or zone thereof with an approved eradication programme for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis;]]]]
|
|
|
(2)
and/or
|
|
[II.2.10.1.3.
|
the animals have been subjected to quarantine for at least 30 days prior to departure and have been subjected to a serological test for the detection of antibodies against whole bovine herpes virus-1 (BoHV-1) with one of the diagnostic methods provided for in Part 5 of Annex I to Delegated Regulation (EU) 2020/688 with a negative result, carried out on a sample taken during the last 15 days prior to the date of departure of the consignment;]]]]
|
|
|
(2)
and/or
|
|
[II.2.10.1.4.
|
the animals are destined for an establishment which keeps bovine animals for meat production without contact to bovine animals of other establishments, and from which they are directly moved to the slaughterhouse;]]]]
|
|
|
|
(2)
or
|
|
[II.2.10.1.
|
they come from establishments not free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, and:
|
II.2.10.1.1.
|
they have been kept in an approved quarantine establishment for at least 30 days prior to the date of departure of the consignment, and
|
|
II.2.10.1.2.
|
they have been subjected to a serological test for the detection of antibodies against whole BoHV-1, with one of the diagnostic methods provided for in Part 5 of Annex I to Delegated Regulation (EU) 2020/688, with a negative result, carried out on a sample taken not less than 21 days after the date of commencement of the quarantine.]]]
|
|
|
|
|
(2) [(2)
either
|
|
[II.2.11.
|
They are moved to a Member State or zone thereof with the status free from bovine viral diarrhoea and they have not been vaccinated against bovine viral diarrhoea, and
|
|
(2)
either
|
|
[II.2.11.1.
|
they come from establishments free from bovine viral diarrhoea, and:
|
|
(2)
either
|
|
[II.2.11.1.1.
|
the establishments of origin are situated in a Member State or zone thereof with the status free from bovine viral diarrhoea;]]]]
|
|
|
(2)
and/or
|
|
[II.2.11.1.2.
|
the establishments of origin have been subjected to a testing regime as referred in Part VI, Chapter 1, Section 2, point 1(c)(ii) or (iii), of Annex IV to Delegated Regulation (EU) 2020/689, carried out, with negative results, within the 4 months period prior to the date of departure of the consignment;]]]]
|
|
|
(2)
and/or
|
|
[II.2.11.1.3.
|
the animals have been tested individually to exclude the presence of bovine viral diarrhoea virus prior to the date of departure of the consignment;]]]]
|
|
|
|
(2)
or
|
|
[II.2.11.1.
|
they come from establishments not free from bovine viral diarrhoea and they have been subjected to a test for bovine viral diarrhoea virus antigen or genome with one of the diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 2020/688, carried out with negative results, and:
|
|
(2)
either
|
|
[II.2.11.1.1.
|
they have been kept in an approved quarantine establishment for a period of at least 21 days prior to the date of departure of the consignment, [and in the case of pregnant dams, they have been subjected to a serological test for the detection of antibodies against bovine viral diarrhoea virus with one of the diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken not less than 21 days after the date of commencement of the quarantine;] (2) ]]
|
|
|
(2)
and/or
|
|
[II.2.11.1.2.
|
they have been subjected to a serological test for the detection of antibodies against bovine viral diarrhoea virus with one of the diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 2020/688, with positive results,
|
|
(2)
either
|
|
[II.2.11.1.2.1.
|
in the case of non-pregnant dams, carried out on samples taken prior to the date of departure of the consignment;]]]]]
|
|
|
(2)
and/or
|
|
[II.2.11.1.2.1.
|
in the case of pregnant dams, carried out on samples taken before the date of insemination preceding the current gestation.]]]]]
|
|
|
|
|
|
(2)
or
|
|
[II.2.11.
|
They are moved to a Member State or zone thereof with an approved eradication programme for bovine viral diarrhoea, and:
|
|
(2)
either
|
|
[II.2.11.1.
|
they come from establishments free from bovine viral diarrhoea, and:
|
|
(2)
either
|
|
[II.2.11.1.1.
|
the establishments of origin are situated in a Member State or zone thereof with the status free from bovine viral diarrhoea;]]]
|
|
|
(2)
and/or
|
|
[II.2.11.1.2.
|
the establishments of origin are situated in a Member State or zone thereof with an approved eradication programme for bovine viral diarrhoea;]]]
|
|
|
(2)
and/or
|
|
[II.2.11.1.3.
|
the establishments of origin have been subjected to a testing regime as referred in Part VI, Chapter 1, Section 2, point 1(c)(ii) or (iii), of Annex IV to Delegated Regulation (EU) 2020/689, carried out, with negative results, within the last 4 months prior to the date of departure of the consignment;]]]
|
|
|
(2)
and/or
|
|
[II.2.11.1.4.
|
the animals have been tested individually to exclude the presence of bovine viral diarrhoea virus prior to the date of departure of the consignment;]]]
|
|
|
(2)
and/or
|
|
[II.2.11.1.5.
|
the animals are destined for an establishment which keeps bovine animals for meat production separate from bovine animals of other establishments, and from which they are directly moved to the slaughterhouse;]]]
|
|
|
|
(2)
and/or
|
|
[II.2.11.2.
|
they come from establishments not free from bovine viral diarrhoea and they have been subjected to a test for bovine viral diarrhoea virus antigen or genome with one of the diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 2020/688, carried out with negative results, and:
|
|
(2)
either
|
|
[II.2.11.2.1.
|
they have been kept in an approved quarantine establishment for a period of at least 21 days prior to the date of departure of the consignment, [and in case of pregnant dams, they have been subjected to a serological test for the detection of antibodies against bovine viral diarrhoea virus with one of the diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken not less than 21 days after the date of commencement of the quarantine;] (2)]]
|
|
|
(2)
and/or
|
|
[II.2.11.2.2.
|
they have been subjected to a serological test for the detection of antibodies against bovine viral diarrhoea virus with one of the diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 2020/688, with positive results,
|
|
(2)
either
|
|
[II.2.11.2.2.1.
|
in the case of non-pregnant dams, carried out on samples taken prior to the date of departure of the consignment;]]]]]
|
|
|
(2)
and/or
|
|
[II.2.11.2.2.1.
|
in the case of pregnant dams, carried out on samples taken before the date of insemination preceding the current gestation.]]]]]
|
|
|
|
|
|
II.3.
|
To the best of my knowledge and as declared by the operator, the animals come from establishments where there were no abnormal mortalities with an undetermined cause.
|
|
II.4.
|
Arrangements are made to transport the consignment in accordance with Article 4 of Delegated Regulation (EU) 2020/688.
|
|
II.5.
|
This animal health certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of animals, the period of validity of the certificate may be extended by the duration of the journey by waterway/sea.
|
|
(2) (6) [II.6.
|
Since the date of departure from their establishments of origin and prior to the date of arrival to this establishment approved for assembly operations, none of the animals of the consignment has undergone more than two assembly operations, and
|
|
(2)
either
|
[they come from their establishments of origin.]]
|
|
(2)
or
|
[at least one of the animals of the consignment has undergone one assembly operation in an approved establishment.]]
|
|
(2)
or
|
[at least one of the animals of the consignment has undergone two assembly operations in the approved establishments.]]
|
Animal welfare attestation
At the time of inspection, the animals covered by this animal health certificate were fit to be transported in accordance with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start on … (insert date)
(7) (8).
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
|
Box reference I.11
|
:
|
“Place of dispatch”: Indicate an establishment of the origin of the animals in the consignment or an establishment approved for assembly operations in accordance with Articles 97 and 99 of Regulation (EU) 2016/429 of the European Parliament and of the Council.
|
|
Box reference I.12
|
:
|
“Place of destination”: Indicate an establishment of the final destination of the consignment or an establishment approved for assembly operations in accordance with Articles 97 and 99 of Regulation (EU) 2016/429.
|
|
Box reference I.17
|
:
|
“Accompanying documents”: In case the animals are dispatched from an establishment approved for assembly operations in the Member State of origin, the reference number(s) of the official document(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operations, may be indicated.
In case the animals are dispatched from an establishment approved for assembly operations in the Member State of passage, the reference number(s) of the certificate(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operations, shall be indicated.
|
|
Box reference I.30
|
:
|
“Identification number”: Indicate identification codes of the animals in the consignment identified in accordance with Article 38 of Delegated Regulation (EU) 2019/2035.
|
Part II:
|
(1)
|
There may be one or more animals in the consignment.
|
|
(2)
|
Delete if not applicable.
|
|
(3)
|
Insert the name of the disease(s).
|
|
(4)
|
Insert the specific reference to the article(s), title, and number of the relevant legal act(s) adopted by the Commission providing for those requirements.
|
|
(5)
|
Insert the specific attestation(s) provided for in and required by the relevant legal act(s) adopted by the Commission, as referred to in Article 126(1), points (b)(ii) and (iii), of Regulation (EU) 2016/429.
|
|
(6)
|
Applicable in case the consignment is dispatched from the establishment approved for assembly operations.
|
|
(7)
|
In the case where a consignment is grouped in an establishment approved for assembly operations and comprises animals that were loaded on different dates, the date which the journey commenced for the whole consignment is considered to be the earliest date when any part of the consignment left the establishment of origin.
|
|
(8)
|
This statement does not exempt transporters from their obligation in accordance with Union rules in force in particular regarding the fitness to be transported.
|
|
In force